1. Home
  2. NWN vs GENB Comparison

NWN vs GENB Comparison

Compare NWN & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northwest Natural Holding Company

NWN

Northwest Natural Holding Company

HOLD

Current Price

$47.08

Market Cap

2.0B

Sector

Utilities

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.18

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NWN
GENB
Founded
1859
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
NWN
GENB
Price
$47.08
$15.18
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
★ $54.33
$23.20
AVG Volume (30 Days)
193.2K
★ 1.3M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
★ 3.71%
N/A
EPS Growth
★ 36.45
N/A
EPS
★ 2.33
N/A
Revenue
★ $1,289,363,000.00
N/A
Revenue This Year
$11.37
N/A
Revenue Next Year
$4.46
$16.58
P/E Ratio
$20.16
★ N/A
Revenue Growth
★ 11.83
N/A
52 Week Low
$43.64
$11.00
52 Week High
$55.99
$22.67

Technical Indicators

Market Signals
Indicator
NWN
GENB
Relative Strength Index (RSI) 32.67 44.03
Support Level $45.72 $14.89
Resistance Level $47.51 $16.75
Average True Range (ATR) 0.83 0.96
MACD -0.16 -0.11
Stochastic Oscillator 17.60 5.61

Price Performance

Historical Comparison
NWN
GENB

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: